The inhibition of FTO reduces GPX4 expression and sensitizes tumor cells to ferroptosis, providing a novel epitranscriptomic mechanism for targeting GPX4 in HNSCC [61]. This evidence concerns the gene GPX4 and head and neck squamous cell carcinoma.